Click HERE to register!

The Scripps Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a comprehensive, case-based curriculum that addresses important clinical topics relevant to cardiomyopathy and cardiovascular health of cancer survivors. Cardio-oncology is a growing field that has great importance as newly developed cancer treatments improve cancer survival rates but can be associated with cardiovascular toxicities. Cardiac amyloidosis, a burgeoning disease with exciting new treatments will also be discussed.

Educational Objectives

After attending this live activity, participants should be able to:

• Assess the risks of oncologic treatment-related cardiac dysfunction for patients who have undergone therapy for cancer.
• Implement strategies for early detection, correction of cardiac risk factors, and close and long-term cardiac monitoring in order to reduce the effects of cardiotoxicity for patients who are at risk of cancer treatment-related cardiac dysfunction.
• Discuss the latest diagnosis and treatment options available for cardiac amyloidosis.
• Evaluate multi-modality imaging such as cardiac magnetic resonance (MR), echocardiography, and nuclear imaging including positron emission tomography (PET) scanning in the diagnosis and follow-up of cardiomyopathy.

Accreditation

Physicians
Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Scripps Health designates this live internet activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.